Dublin, April 04, 2017 -- Research and Markets has announced the addition of the "Defibrillator Devices Global Market - Forecast to 2023" report to their offering.
The Defibrillator Devices Global Market is Expected to Grow at a Mid to High Single Digit CAGR to Reach $17,710.8 Million by 2023
Among the defibrillator devices products market implantable cardioverter defibrillators segment holds the largest share of the market and external defibrillators is expected to be the fastest growing segment. In applications market ventricular tachycardia holds the largest share of the market and ventricular fibrillation is expected to grow with a strong CAGR from 2016 to 2023. In end-users, hospitals are the largest segment and home healthcare is the fastest growing segment from 2016 to 2023.
Geographically, North America is the largest market followed by Europe and Asia Pacific. The APAC region is the fastest growing region from 2016 to 2023 presenting an array of opportunities for growth and is likely to get attention of new investors in the defibrillator devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The defibrillator devices market is expected to grow at a single high digit CAGR during 2016 to 2023. Increase in aging population and subsequent rise in incidence of cardiovascular diseases, increasing use of defibrillators in public access areas and favorable reimbursement policies are the factors driving the market growth. Increasing trend of MRI compatible defibrillators, emergence of next generation integrated ICD's and market expansion opportunities in emerging nations are expected to offer potential opportunities.
However, various factors like patient safety risks due to chances of infection and other complications while using defibrillators, lack of awareness on sudden cardiac arrests limit the growth of defibrillator devices global market. The threats for the defibrillator devices market include lack of cybersecurity in ICD's and increasing number of defibrillator device recalls due to FDA mandates.
Factors Influencing Market
Drivers and Opportunities
- Increase in Aging Population and Subsequent Rise in Incidence of Cardiovascular Diseases
- Increasing Use of Defibrillators in Public Access Areas
- Favorable Reimbursement Policies
- Emergence of Next Generation Integrated ICD's
- Increasing Trend for MRI Compatible Defibrillators
- Market Expansion Opportunities in Emerging Nations
Restraints and Threats
- Patient Safety Risks Due to Chances of Infections and Other Complications While Using Defibrillators
- Lack of Awareness on Sudden Cardiac Arrests
- Lack of Cybersecurity in ICD's
- Increasing Number of Defibrillator Devices Product Recalls Due to Fda Mandates
Companies Mentioned
- 3B Scientific GmbH
- A.M.I. Italia S.R.L
- Abbott Laboratories
- Allied Medical Limited
- Asahi Kasei Corporation
- Bexen Cardio
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- BPL Medical Technologies
- Corpuls
- CU Medical Systems Inc
- Cura Healthcare Pvt Ltd
- Dixion Vertrieb Medizinischer Geräte GmbH
- Electromedicals
- Emtel Sliwa SP.K.
- Fukuda Denshi
- Gaumard Scientific
- HD1PY
- Innomed Medical Developing and Manufacturing
- Instramed
- Integer Holdings Corporation
- Life Plus Medical Inc
- Lifebot
- Livanova Plc
- M&B Electronic Instruments
- Mediana
- Medical Econet GmbH
- Meditech
- Medtronic Plc
- Metrax GmbH
- Metsis Medikal
- Mindray
- Minnesota Wire
- MS Westfalia GmbH
- Nanoomtech
- Narang Medical Limited
- Nasan Medical Electronics Pvt Ltd
- Nihon Kohden Corporation
- Orientmed International FZE
- Philips Healthcare
- Promed Co Ltd
- Rapid Diagnostics Pvt Ltd
- Ritim Grup AS
- Rotaid
- Schiller
- Shenzhen XFT Electronics
- Simulaids
- Stryker Corporation
- Techno-Gaz
- US Defib Medical Technologies
- Weinmann Emergency Medical Technology
- Xincheng Scientific Industries Co., Ltd.
- Yuan Technology Limited
For more information about this report visit http://www.researchandmarkets.com/research/npr6b3/defibrillator
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Devices


AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal
Boeing Reaches Tentative Settlement With Canadian Victim’s Family in 737 MAX Crash Lawsuits
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes 



